Temsirolimus

Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative and prodrug of sirolimus and is sold as Torisel.

单词	Temsirolimus
释义	Temsirolimus 英语百科 Temsirolimus Temsirolimus (CCI-779) is an intravenous drug for the treatment of renal cell carcinoma (RCC), developed by Wyeth Pharmaceuticals and approved by the U.S. Food and Drug Administration (FDA) in late May 2007, and was also approved by the European Medicines Agency (EMEA) on November 2007. It is a derivative and prodrug of sirolimus and is sold as Torisel.
随便看	Measles Vaccine, Live measles vaccine live Measles Vaccine,Live measles varicosis measles virus measles virus F protein measles virus genome Measles Virus,German measles virus H protein measles virus vaccine measles virus vaccine,live measles virus vaccine live measlesvoccine measles with favourable prognosis Measles with other specified complications measles without adequate eruption to expel toxins Measles without eruption Measles without mention of complication measles with red and elevated rashes Measles with unspecified complication measle vaccine measly measliness measlings measly aphasia